By Peter Scholz // PCRI Creative Director
The PCRI Reaches 20 Years of Service
2016 marks the year that the Prostate Cancer Research Institute is two decades old! Your support has enabled us to help men and caregivers solve problems that they face today, with support, actionable information, and education.
Hello Researcher! We are excited to bring you a new issue of Prostate Insights. This year is a milestone in PCRI’s history and we are grateful for all of your support which has allowed us to make it this far and to flourish.
When PCRI was founded, Drs. Scholz and Strum worked tirelessly to translate medical information from peer reviewed journals into materials that were usable by patients, to combat widespread lack of accessible medical information. As the prostate cancer landscape has shifted with the advent of new treatments, technology, and the internet, we have evolved to address the problem that the patient community faces today: Widespread misinformation. This organization began on the principle that an informed patient receives a better and more wholesome outcome.
Our focus has been and always will be the educational needs of the patient and all of our programs and materials exist for this simple goal.
We are grateful for the support you give us that allows us to continue to partner with leading doctors and researchers to bring you the latest relevant prostate cancer information and developments that you can use today. In this coming year, we are excited to announce new and exciting partnerships with celebrities and with sports organizations to help us battle prostate cancer through education.
In this issue, we are announcing an exciting partnership with Emmy Winning Actor Ed Asner who will be performing a one-man comedy play directly following our 2016 Moyad + Scholz Mid-Year Update. Also, we are detailing an exciting addition to our Board of Directors and our Medical Review Board: Fabio Almeida, MD, from Phoenix Molecular Imaging. Jonathan Epstein, MD—a leading pathologist, from Johns Hopkins University—answers common questions about the Gleason scoring system and pathology reports. Also, our conference moderator, long time partner of PCRI, and best-selling author, Mark Moyad, MD, shares his expert opinion on 5 important vaccines, and why you should consider taking them. He also covers some unexpected side benefits of being vaccinated and sheds light on the types of vaccines available.
Our second annual Moyad + Scholz Mid-Year Update is just around the corner and we are excited to announce an esteemed speaker lineup. This issue contains details about the event, and registration information. Lastly, our helpline facilitator Bob Each, shares the inspiring story of his own prostate cancer journey.
We are excited to begin this new year and are working tirelessly to bring you the most trustworthy, understand-able, informative, and entertaining educational experience that we can offer.